It is suggested that AMS can upregulate Smad7 and competitively inhibit β-catenin through both classical Wnt/β-catenin pathway and crosspoilers with TGF-β, and finally reduce β-catenin expression and interfere with PF(Yu et al., 2018). The gene discussed is TGFB1; the disease is pemphigus foliaceus.